Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1364667A
Inventor
Josef Wagner
Wolfgang Schlemmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Deutschland GmbH
Original Assignee
Klinge Pharma GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Pharma GmbH and CofiledCriticalKlinge Pharma GmbH and Co
Priority to GB1364667ApriorityCriticalpatent/GB1116890A/en
Publication of GB1116890ApublicationCriticalpatent/GB1116890A/en
C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
C07H15/20—Carbocyclic rings
C07H15/24—Condensed ring systems having three or more rings
C07H15/256—Polyterpene radicals
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
Life Sciences & Earth Sciences
(AREA)
Engineering & Computer Science
(AREA)
Biochemistry
(AREA)
Biotechnology
(AREA)
General Health & Medical Sciences
(AREA)
Genetics & Genomics
(AREA)
Molecular Biology
(AREA)
Medicines Containing Plant Substances
(AREA)
Abstract
Alpha-aescin having a haemolytic index of 15,000-22,000 is prepared from beta-aescin by leaving the beta form to stand in aqueous solution at a pH of 4.5-7.5. The beta-aescin is obtained from the horse-chestnut tree. Reference has been directed by the Comptroller to Specifications 933,657 and 929,816.
GB1364667A1967-03-231967-03-23Process for the preparation of a water-soluble horse-chestnut saponin
ExpiredGB1116890A
(en)
Process for the preparation of a water-soluble complex of the 8-hydroxy-quinoline - (- sulfonate of 1,5-dimethyl-4-dimethyl-amino-2-phenyl-3-isopyrazolone
A procedure for obtaining stable, aqueous and injectable solutions, with associations of monofeni 4 butilpirazolidina. (Machine-translation by Google Translate, not legally binding)